Evidence map›Paper›PMID 7969117›Full record

ArticleMolecular and cellular biology1994

Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

L Dailey, H Yuan, C Basilico

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Transcription factor heterogeneity and epiblast pluripotency.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2011
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

L DaileyRockefeller University, New York, New York 10021.
H Yuan
C Basilico

Funding

ULTRASONIC ABSORPTION BY BIOLOGICAL MEDIAR01CA045689 · NCI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI DUNN, FLOYD · 1988 to 1991
–
REGULATORY MECHANISMS IN THE GI PHASE OF THE CELL CYCLER29CA049472 · NCI · ROCKEFELLER UNIVERSITY · PI DAILEY, LISA A · 1989 to 1993
–
NCI NIH HHS CA45689NCI NIH HHS CA49472
6 · The paper itself

Abstract

Understanding how diverse transcription patterns are achieved through common factor binding elements is a fundamental question that underlies much of developmental and cellular biology. One example is provided by the fibroblast growth factor 4 (FGF-4) gene, whose expression is restricted to specific embryonic tissues during development and to undifferentiated embryonal carcinoma cells in tissue culture. Analysis of the cis- and trans-acting elements required for the activity of the previously identified FGF-4 enhancer in F9 embryonal carcinoma cells showed that enhancer function depends on sequences that bind Sp1 and ubiquitous as well as F9-specific octamer-binding proteins. However, sequences immediately upstream of the octamer motif, which conform to a binding site for the high-mobility group (HMG) domain factor family, were also critical to enhancer function. We have identified a novel F9-specific factor, Fx, which specifically recognizes this motif. Fx formed complexes with either Oct-1 or Oct-3 in a template-dependent manner. The ability of different enhancer variants to form the Oct-Fx complexes correlated with enhancer activity, indicating that these complexes play an essential role in transcriptional activation of the FGF-4 gene. Thus, while FGF-4 enhancer function is octamer site dependent, its developmentally restricted activity is determined by the interaction of octamer-binding proteins with the tissue-specific factor Fx.

Indexed as

Enhancer Elements, GeneticAnimalsBase SequenceCell LineDNA-Binding ProteinsFibroblast Growth Factor 4Fibroblast Growth FactorsGene Expression Regulation, DevelopmentalHost Cell Factor C1Macromolecular SubstancesMiceMolecular Sequence DataMutagenesis, Site-DirectedNuclear ProteinsOctamer Transcription Factor-1Octamer Transcription Factor-3DNA-Binding ProteinsFgf4 protein, mouseFibroblast Growth Factor 4Fibroblast Growth FactorsHcfc1 protein, mouseHost Cell Factor C1Macromolecular SubstancesNuclear ProteinsOctamer Transcription Factor-1Octamer Transcription Factor-3Pou2f1 protein, mousePou5f1 protein, mouseProto-Oncogene ProteinsSp1 Transcription FactorTranscription Factors

Identifiers

PMID7969117
PMCPMC359316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.